In summary, our current study elucidated that wogonoside could prevent colitis-associated colorectal carcinogenesis and inhibit colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway. Here, AKT1 is linked to malignant colon neoplasm.